【文/观察者网专栏作者 文少卿】 12月8日，日本驻越南大使伊藤直树亲口告诉英国路透社，因为时间表"太紧"，日本已退出在越南建设大型核电站的计划。 简单来说，就是"太君"提桶跑路了。而且连句委婉的"条件尚不成熟"都懒得编，直接搬出打工人最熟悉的甩锅金句，就把越南人的核电蓝图，乃至缔造"下 一个亚洲奇迹"的美梦，直接扔在了12月的寒风里瑟瑟发抖。 核能，越南的救命稻草 越南缺电，这不是新闻。 工厂24小时连轴转，给三星、苹果和富士康代工的流水线不敢停；中产阶级家里空调、电动车、智能家电齐上阵；再加上动不动就40℃的热浪和说来就来的 台风，水电站一干涸，电网立马"罢工"。于是乎，停电成了家常便饭。 2023年6月，越南北部遭遇严重电力短缺，导致大面积轮流停电，直接让三星和富士康产线停摆，连英特尔都吓得撤回了扩产计划，越南"世界工厂替补队 员"的人设，差点当场崩盘。今年12月4日，越南国会主席陈青敏就直言不讳：如今外国老板们飞到河内或胡志明市，落地第一句不是问政策、问地价，而是 直奔主题："你们这儿……电够用吗？" 越南政府当然心知肚明。"越南的目标是在2025年实现8%或更高的经济增长，并在随后几年实现两位数的经 ...

Core Viewpoint - The stock price of Moer Thread has surged since its debut on the Sci-Tech Innovation Board, with a market value exceeding 440 billion yuan, leading to significant market attention regarding its cash management plans [1] Group 1: Financial Management - Moer Thread announced plans to use up to 7.5 billion yuan of idle raised funds for cash management, a figure close to its IPO net fundraising amount [1] - The company clarified that the 7.5 billion yuan is the upper limit for cash management, and the actual amount will be significantly lower, with adjustments as project progress occurs [1] - The cash management strategy aims to enhance fund efficiency while ensuring the smooth implementation of fundraising projects and safeguarding the interests of shareholders [1] Group 2: Business Operations and Performance - The company reported a revenue of 785 million yuan and a net loss of 724 million yuan for the first nine months of 2025, with projected losses for the full year ranging from 730 million to 1.168 billion yuan [4] - Moer Thread is committed to increasing R&D investment to accelerate product iteration and overcome core technological barriers, ensuring that cash management does not affect the normal operation of fundraising projects and core business [2] - The company acknowledges existing gaps in R&D capabilities and product ecosystem compared to international giants, with new products still in the development stage and not yet generating revenue [4] Group 3: Market Performance - As of December 12, Moer Thread's stock price fell over 13%, bringing its market value down to 383 billion yuan [4] - The stock has experienced significant volatility, prompting the company to issue a risk warning regarding potential irrational market behavior and the risks associated with rapid price increases [4]

2025年8月21日20时01分，福建省三明市广丰矿业有限公司水井坑煤矿（以下简称水井坑煤矿）发生一起较大瓦斯爆炸事故，造成7人遇难、1人轻微伤，直 接经济损失约926万元。 调查报告称，事故直接原因在于，三采区+180mC39S运输巷掘进迎头煤层赋存条件变化，煤层变厚、倾角变大、煤细碎松软，浮煤边清边冒，瓦斯持续涌 出并在迎头高冒区大量聚集，且与紧邻的+180m石门高冒区溢出瓦斯汇聚，风量不足导致瓦斯积聚达到爆炸浓度，爆源区域内作业人员打火抽烟引发瓦斯爆 炸。 事故现场实测图 报告称，在+180mC39S工作面冒落的煤堆浅部发现半包香烟，在爆源点附近处发现打火机零件，在石门高冒区附近发现打火机残骸碎片。 12月12日，国家矿山安全监察局福建局发布《福建三明广丰矿业有限公司水井坑煤矿"8·21"较大瓦斯爆炸事故调查报告》。 水井坑煤矿总工程师、生产副矿长、安全副矿长、采掘队长、当班检身工等5名责任人员涉嫌犯罪，被建议移送司法机关追究刑事责任。 水井坑煤矿机电副矿长等12人被分别给予党纪政务处分、解除劳动合同等处理。 水井坑煤矿矿长等15名人员被撤销或暂扣执业资格、特种作业操作证，9名安全管理人员予以行政罚款， ...

【文/观察者网 阮佳琪】 特朗普政府时期，美国将重心放在石油、天然气和煤炭的开采与海外销售上；而作为其主要经济竞争对 手的中国，早已跃居全球太阳能电池板、电池及电动汽车等清洁能源产品的最大供应国。 也因此，美媒《纽约时报》关注起了中美角力的新战场——核聚变。其发表于13日的报道指出，这项蕴 藏着无限清洁能源潜力的技术，其突破或将重塑两国乃至全球的能源格局。 美媒在报道中对比称，中美两国的核聚变研发路径截然不同：美国寄望于私营产业与市场创新驱动技术 突破，但其政府对该领域的支持力度屡遭诟病；而在地球另一端，中国已将核聚变列为国家优先发展事 项，正以惊人的速度调集资源推进研发、建设大型实验设施，目标明确地致力于在未来几年内实现关键 性技术突破。 报道指出，这场能源竞赛不仅关乎谁能率先掌握核聚变这项科学难题，更重要的是，获胜者将拥有重塑 全球能源格局和地缘政治联盟的能力，从而主导未来的清洁能源市场。 今年年初回国并入职北京大学的核物理学家刘畅，在接受美媒采访时透露了他的切身感受：此前在美国 普林斯顿等离子体物理实验室工作期间，他的团队因预算不足无法招募年轻科研人员。他直言，美国政 府支持力度欠缺，正是众多核聚变研究 ...

【文/观察者网 阮佳琪】 "我们的业务遍及全球55个国家，其中52个国家的能源项目都在使用中国生产的光伏组件及相关设备， 覆盖范围既包括美国、印度、中东国家，也涵盖了非洲与东南亚地区。" 谈及中国在可再生能源全产业链中的主导地位时，全球可再生能源工程咨询公司SgurrEnergy董事阿里 夫·阿加（Arif Aga）向香港《南华早报》如是说道。 据港媒13日报道，这位可再生能源技术顾问坦言，全球绿色能源转型的核心逻辑，从来不是地缘政治博 弈，而是实实在在的经济现实。对众多寻求发展清洁能源的国家而言，降低成本的务实需求始终是其首 要考量。 也正是这一现实，奠定了中国在全球清洁能源供应链中的领先地位。阿加指出，中国制造业的庞大产能 与快速技术迭代，共同推动行业成本大幅下降，毋庸置疑已然成为全球能源转型的关键驱动力。 公开资料显示，阿加在SgurrEnergy亚洲市场的战略布局中扮演着关键角色。通过聚焦中国和印度这两 个全球可再生能源增长最快的市场，他推动SgurrEnergy从一家以风能咨询为主的英国公司，转型为涵 盖太阳能、储能和混合能源的全球技术咨询领导者。 历经数十年行业深耕，阿加认为，中国在绿色能源技术革 ...

Core Insights - Long-duration energy storage technology is essential for addressing the volatility of renewable energy and creating an all-weather green electricity system, particularly for high-energy-consuming industries like AIDC [1] - The third annual Haicheng Energy Storage Ecological Day successfully showcased three innovative products aimed at solving core pain points in renewable energy consumption and AIDC energy transformation [1][2] - The event gathered experts and industry partners to discuss new technologies, pathways, and scenarios for the development of the long-duration energy storage industry [1] Innovative Products - The world's first native 8-hour long-duration energy storage solution, Power8 6.9MW/55.2MWh, is designed to stabilize renewable energy generation fluctuations and provide all-weather stable power supply [2] - The world's first 8-hour long-duration energy storage dedicated cell, Cell 1300Ah 8h, supports deep cycling for 8 hours and boasts a lifespan of over 25 years, with significant cost advantages and high safety [2] - The world's first lithium-sodium collaborative AIDC all-time energy storage solution, Power Solutions For AI Data Center, meets the core demand for stable power in AIDC scenarios while adapting to high instantaneous power consumption [2] Industry Discussions - A roundtable forum discussed the critical role of energy storage in achieving zero-carbon AIDC, with insights on technology innovation, cost control, and scenario adaptation [3] - The 2025 China AIDC Energy Storage Industry Blue Book was jointly released, providing comprehensive references for the industry from demand to implementation [3] Future Directions - The company aims to drive the marketization of energy storage through economic viability and technological innovation, targeting a cost of energy storage (LCOS) to enter the "0.1 yuan era" within five years [4] - The focus will be on high safety, long lifespan, and high efficiency in large-size cells, as well as integrated solutions and extreme intelligent manufacturing [4] - The ongoing integration of AI, electrification, and energy transformation presents significant development opportunities for the "new energy + long-duration storage" sector [4]

近日，山东一村支书称在网上卖农作物小米，被小米公司法务"关联雷氏营销"投诉下架视频一事引起热 议。12月12日，@小米公司发言人 发布澄清说明，回应所谓"小米公司不让卖小米"一事。主要内容如 下： 长期以来，小米一直积极支农、助农，通过各种方式助力乡村振兴，履行社会责任。目前，小米已在贵 州、云南、湖南、河北、新疆等多地捐赠支持乡村学校及农场发展。以"小米图书馆"为例，2019年起， 小米公益基金会向新疆、云南、贵州等地捐赠建立7所小米图书馆，并持续捐赠资金，支持开展乡村文 化及教育振兴。 《大河报》注意到，该博主曾于9月5日发布一条题为"如果用雷军方式介绍黄小米"的视频，以新闻发布 会的形式推介农产品，并在文案中使用了"小米发布会"、"雷军"等标签。目前，该视频已被删除。 "相关视频内容，完全失实，是彻头彻尾的歪曲与污蔑。此前，我司对该账号部分内容的投诉，针对的 是其恶意模仿、捏造污蔑，对我司及我司高管名誉的侵害行为，并非针对"小米"二字或"小米"农产品的 正常使用。将投诉行为曲解为"不让用'小米'二字"，是偷换概念，以"助农"议题为名，行污蔑造谣、博 取流量之实。 运用法律武器，坚决维护自身合法权益，是每 ...

Core Viewpoint - The auction of "Jiu Bian Li," a pioneer in the liquor pre-storage model, highlights the challenges faced by the liquor retail industry, including high costs, low margins, and a significant decline in valuation due to market conditions and management issues [1][2][7]. Group 1: Auction Details - On December 9, "Jiu Bian Li" was auctioned for a total price of 68.4 million yuan, with "Qiongqing City Chuang Dongfang Huake" acquiring 51% of the shares [1][2]. - The auction attracted 26,600 viewers, and the shares were sold at 71% of the market price, reflecting a significant drop in valuation from previous years [2]. Group 2: Financial Performance - In 2024, "Jiu Bian Li" reported a revenue of 1.679 billion yuan, a slight decrease of 3.8% year-on-year, but net profit turned into a loss of 109 million yuan, marking a decline of 470% [7][8]. - By the first half of 2025, revenue further declined to 598 million yuan, a nearly 40% drop, with a loss of 61.55 million yuan [8]. Group 3: Business Model Challenges - The liquor retail industry faces high fulfillment costs and low margins, with a gross margin of less than 15% and a net margin below 3% after accounting for various costs [10][11]. - Liquor consumption has a longer repurchase cycle compared to other consumer goods, making it difficult for the instant delivery model to achieve profitability [12][13]. Group 4: Management and Operational Issues - The actual controller of "Jiu Bian Li," Yu Zengyun, has been implicated in legal issues, leading to a freeze on assets and a significant disruption in financing [5][6]. - The company’s liabilities reached 330 million yuan, with an asset-liability ratio of 74%, indicating a precarious financial situation [6]. Group 5: Future Opportunities - Despite current challenges, there may be opportunities in the liquor retail sector by targeting younger demographics with differentiated services that focus on convenience and experience [15].

Core Insights - The successful treatment of a child with restrictive cardiomyopathy using a "dual artificial heart implantation + heart transplant" marks a significant breakthrough in China's pediatric end-stage heart failure treatment and domestic artificial heart application [2] - This operation is the lightest successful case globally in similar surgeries, showcasing over a decade of technological accumulation and integration in China's artificial heart industry [2] Market Overview - The global ventricular assist device market is projected to reach approximately $2.2 billion in 2024 and $2.5 billion by 2025 [2] - The Chinese market, although starting later, is experiencing rapid growth, with an expected market size of 33.2 million yuan for implantable ventricular assist devices in 2024 [2] - Multiple domestic companies have received approval for market entry, and Beijing has included artificial hearts in Class A medical insurance reimbursement as of September 2024, with nationwide implementation expected by March 2025 [2] Technological Advancements - The innovative approach taken by Tianjin TEDA International Cardiovascular Hospital and Aerospace TaiXin Technology involves a second-generation magnetic levitation artificial heart, which enhances reliability by eliminating electronic systems that could fail [5][6] - The design modifications for the artificial heart to accommodate the child's small heart chamber included reducing the thickness from 25 mm to 11 mm and the overall weight to below 75 grams, representing a significant engineering breakthrough for pediatric usability [6] Unique Treatment Approach - The surgery also filled a global gap by introducing a dedicated right heart pump, allowing for a dual heart system in pediatric patients, which previously had limited options and often relied on heart transplants [7] - This transition from external dependency to fully implanted systems significantly reduces infection risks and enhances patient mobility, redefining the quality of life for patients [7]

Core Insights - The 2025 National Medical Insurance Drug List has been officially released, adding 114 new drugs, including 50 innovative Class 1 drugs, with a negotiation success rate of 88%, the highest in seven years [1][3] - The first version of the commercial insurance innovative drug list has been introduced, featuring 5 CAR-T cell therapies and 19 high-priced innovative drugs, marking a significant expansion in coverage [1][5] - The adjustment reflects a strategic upgrade in China's medical insurance from "basic coverage" to "basic + high-end coverage," addressing the demand for accessible and affordable innovative drugs [1][9] Drug Additions and Market Impact - The new drug list includes 114 drugs, with 44% being Class 1 innovative drugs, and a total of 3,253 drugs now covered under the insurance [3] - Notable winners include Heng Rui Pharma, which secured 20 new drug approvals, and Eli Lilly, whose drug Tirzepatide has entered the Chinese market, benefiting 140 million diabetes patients [3][4] - The inclusion of CAR-T therapies in the commercial insurance list allows for reimbursement of high-cost treatments, which were previously inaccessible to many patients [5][7] Innovations in Treatment - The new list includes significant advancements in treatments for Alzheimer's disease, with two new drugs targeting amyloid beta accumulation, providing options for over 10 million patients in China [7] - The addition of 13 rare disease drugs fills coverage gaps in four rare disease areas, expanding the total number of rare disease drugs covered to approximately 100 [8] - The adjustment also emphasizes pediatric medications, with a separate review channel for children's formulations, indicating a positive shift in addressing children's healthcare needs [9] Strategic Implications - The 2025 adjustment signifies a shift towards a dual-track medical payment system in China, combining basic medical insurance with commercial insurance to meet both fundamental and advanced healthcare needs [9] - The rapid inclusion of innovative drugs into the insurance system reflects a decade of progress in China's pharmaceutical landscape, transitioning from rare domestic innovations to a robust pipeline of new therapies [9]